BIBLIOTEKA . Library :. LAW, RULES & LEGISLATIONS
- 25 States Eye Right-to-Try Legislation.docx Office Open XML Document 25249KB
- 3 Ridiculous Ways the FDA Is Policing Social Media.DOC DOC File 86016KB
- Are Fat Stem Cells a Drug.docx Office Open XML Document 104198KB
- ARM Reimbursement Portfolio Oct 2013.pdf PDF File 1658437KB
- Australia code of GMP for human blood tissues 2013.pdf PDF File 321268KB
- Autologous cell therapies challenges in US FDA regulation.pdf PDF File 321440KB
- Considerations for the Design of Early Phase Clinical Trials of Cellular and Gene Therapy Products.pdf PDF File 320423KB
- Deborah Hursh presentation.pdf PDF File 751721KB
- Deterministic and stochastic approaches in the clinical application of MSCs.pdf PDF File 3164617KB
- Disgraced Scientist Granted U.S. Patent for Work Found to be Fraudulent.DOC DOC File 29696KB
- Draft Guidance for Industry.pdf PDF File 64067KB
- European Medicines Agency recommends approval of combined advanced therapy product.pdf PDF File 74396KB
- European Medicines Agency recommends approval of combined advanced-therapy product.pdf PDF File 74396KB
- Everyone Deserves the Right to Try - Empowering the Terminally Ill to Take control of their treatment.pdf PDF File 1389599KB
- Fatalities Reported to FDA Following Blood Collection and Transfusion.pdf PDF File 94313KB
- FDA approves next phase of stem cell research.docx Office Open XML Document 95048KB
- FDA Clears ISCO's Stem Cell Line for Clinical Uses.PDF PDF File 7075KB
- FDA has repeatedly hidden evidence of scientific fraud.docx Office Open XML Document 371846KB
- FDA just simplified the compassionate use process.docx Office Open XML Document 15226KB
- Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal drugs and biologics.pdf PDF File 120474KB
- Guideline on Risk characterisation and assessment of Maximum Residue Limits (MRL) for biocides.pdf PDF File 214201KB
- Homologous Use of Human Cells, Tissues, and Cellular and Tissue Based Products.pdf PDF File 122645KB
- Human genes cannot be patented, US court says.doc DOC File 44032KB
- Inside the FDA Mafia.DOC DOC File 26112KB
- International Regulatory Considerations on Development Pathways for Cell Therapies.pdf PDF File 1212472KB
- Is this human gene robbery.doc DOC File 52224KB
- Japan to offer fast-track approval path for stem cell therapies.doc DOC File 208896KB
- Legal and Regulatory News from Europe.pdf PDF File 292585KB
- Looser laws make Japan a magnet for stem cell businesses.docx Office Open XML Document 30720KB
- Michael Werner presentation.pdf PDF File 1237739KB
- NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AN OPPORTUNITY TO EXPLAIN (NIDPOE).pdf PDF File 450913KB
- Optimizing FDAs Regulatory Oversight of Next Generation Sequencing Diagnostic Tests Preliminary Discussion Paper.pdf PDF File 433954KB
- Paul Kemps presentation.pdf PDF File 1752064KB
- Proof That the FDA Is not Protecting Americans Health.docx Office Open XML Document 255138KB
- Regulation of stem cell therapies under attack in Europe for whom the bell tolls.docx Office Open XML Document 93078KB
- Regulatory Insight into the European hPSC Registry.pdf PDF File 320184KB
- Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.pdf PDF File 1171411KB
- Research Misconduct Identified by the US FDA.pdf PDF File 346328KB
- Responsible use of human primary materials.DOC DOC File 30208KB
- Scientists challenge patent ban for embryonic stem cell research.doc DOC File 43008KB
- Stem Cell Lines Not Fit for Clinic.DOC DOC File 114688KB
- Stem cell therapy is the US missing a trick.docx Office Open XML Document 114909KB
- Stetement on Genome Editing Technologies and Human Germline Genetic Modification.pdf PDF File 139507KB
- Tech Companies Struggle with FDA Regulation.DOC DOC File 27648KB
- The FDA is finally embracing health tech thats both good and bad news.docx Office Open XML Document 156037KB
- The REGROW Act- an urgent demand for a new FDA regulatory pathway to accelerate safe cell therapies.docx Office Open XML Document 15731KB
- Under 21st Century Cures legislation, stem cell advocates expect regulatory shortcuts.docx Office Open XML Document 16174KB
- Understanding EU regulation of cell based medicinal products.pdf PDF File 960512KB
- Understanding The Regulatory Framework For Stem Cell.pdf PDF File 751721KB
- UNLOCKING THE CODE OF HEALTH.pdf PDF File 6404551KB
- US FDA Issues Warning Letter To Stem Cell Treatment Centers.docx Office Open XML Document 14951KB
- US-PATENT METHODS, PHARMACEUTICAL COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR ADMINISTERING THERAPEUTIC CELLS TO THE ANIMAL CNS.pdf PDF File 3125822KB
- VICH GL34 Biologicals testing for the detection of mycoplasma contamination.pdf PDF File 218134KB
- VICH GL50 Biologicals testing harmonisation of criteria to waive target animal batch safety testing for inactivated vaccines for veterinary use.pdf PDF File 160429KB
- VICH GL51 Quality statistical evaluation of stability data.pdf PDF File 218171KB
- Why GMP An explanation of Good Manufacturing Practice.docx Office Open XML Document 83023KB
- Yamanaka patent.pdf PDF File 86450KB